Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

1.

Human Opiorphin, a natural antinociceptive modulator of opioid-dependent pathways.

Wisner A, Dufour E, Messaoudi M, Nejdi A, Marcel A, Ungeheuer MN, Rougeot C.

Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17979-84. Epub 2006 Nov 13.

PMID:
17101991
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Enkephalinase inhibitors: potential agents for the management of pain.

Thanawala V, Kadam VJ, Ghosh R.

Curr Drug Targets. 2008 Oct;9(10):887-94. Review.

PMID:
18855623
[PubMed - indexed for MEDLINE]
3.

Biochemical properties of recombinant prolyl dipeptidases DPP-IV and DPP8.

Chen X.

Adv Exp Med Biol. 2006;575:27-32. Review. No abstract available.

PMID:
16700505
[PubMed - indexed for MEDLINE]
4.

Dual inhibitors of enkephalin-degrading enzymes (neutral endopeptidase 24.11 and aminopeptidase N) as potential new medications in the management of pain and opioid addiction.

Roques BP, Noble F.

NIDA Res Monogr. 1995;147:104-45. Review. No abstract available.

PMID:
8742783
[PubMed - indexed for MEDLINE]
5.

The role of opiorphins (endogenous neutral endopeptidase inhibitors) in urogenital smooth muscle biology.

Davies KP.

J Sex Med. 2009 Mar;6 Suppl 3:286-91. doi: 10.1111/j.1743-6109.2008.01186.x. Review.

PMID:
19267851
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Protection of endogenous enkephalin catabolism as natural approach to novel analgesic and antidepressant drugs.

Noble F, Roques BP.

Expert Opin Ther Targets. 2007 Feb;11(2):145-59. Review.

PMID:
17227231
[PubMed - indexed for MEDLINE]
7.

Enzymatic degradation of endomorphins.

Janecka A, Staniszewska R, Gach K, Fichna J.

Peptides. 2008 Nov;29(11):2066-73. doi: 10.1016/j.peptides.2008.07.015. Epub 2008 Jul 31. Review.

PMID:
18718496
[PubMed - indexed for MEDLINE]
8.

Opioids in chronic pain.

Przewłocki R, Przewłocka B.

Eur J Pharmacol. 2001 Oct 19;429(1-3):79-91. Review.

PMID:
11698029
[PubMed - indexed for MEDLINE]
9.

Association of enkephalin catabolism inhibitors and CCK-B antagonists: a potential use in the management of pain and opioid addiction.

Roques BP, Noble F.

Neurochem Res. 1996 Nov;21(11):1397-410. Review.

PMID:
8947930
[PubMed - indexed for MEDLINE]
10.

Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor.

Meunier JC.

Eur J Pharmacol. 1997 Dec 4;340(1):1-15. Review.

PMID:
9527501
[PubMed - indexed for MEDLINE]
11.

Opioid-modulating properties of the neuropeptide FF system.

Moulédous L, Mollereau C, Zajac JM.

Biofactors. 2010 Nov-Dec;36(6):423-9. doi: 10.1002/biof.116. Epub 2010 Aug 27. Review.

PMID:
20803521
[PubMed - indexed for MEDLINE]
12.

[Enkephalin catabolism inhibitors and antalgics of the future: from preclinical research to clinical trials].

Noble F, Fournié-Zaluski MC, Roques BP.

Therapie. 1999 Jan-Feb;54(1):121-33. Review. French.

PMID:
10216436
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk